Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules
The company to market a generic equivalent of Trokendi XR Extended-Release Capsules
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA approval
Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication
ONYDA XR is indicated for the treatment of ADHD as monotherapy or as adjunctive therapy to approved CNS stimulant medications in…
Bristol Myers Squibb’s cell therapy gets USFDA nod for relapsed or refractory follicular lymphoma
95.7 per cent of patients responded to Breyanzi in the TRANSCEND FL trial
Gland Pharma receives USFDA approval for Edaravone Injection
The product is used to treat amyotrophic lateral sclerosis (ALS)
Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData
GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…
USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa
Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release…
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz Extended-Release tablets, 4 mg…
USFDA gives final nod to Zydus Lifesciences’ generic version of insomnia drug
The drug, triazolam, is used on a short-term basis to treat insomnia
US FDA approves TG Therapeutics’ multiple sclerosis drug
The approval by the US Food and Drug Administration (USFDA) widens the number of such drugs available for treating the disorder to…
USFDA approves Roche’s lymphoma therapy
The drug, known chemically as mosunetuzumab, can be administered at a hospital’s outpatient centre, unlike some other follicular…